Atenolol 25 mg po daily

APA 3-page paper with at least 4 references that addresses the following:

  • 1. Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
  • 2. Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study above.
  • 3. Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  • 4. Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
  • CASE STUDY: Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following: 
  • Glipizide 10 mg po daily
  • HCTZ 25 mg daily
  • Atenolol 25 mg po dailyAPA 3-page paper with at least 4 references that addresses the following:
    • 1. Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
    • 2. Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study above.
    • 3. Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
    • 4. Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
    • CASE STUDY: Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following: 
    • Glipizide 10 mg po daily
    • HCTZ 25 mg daily
    • Atenolol 25 mg po daily
    • Hydralazine 25 mg qid
    • Simvastatin 80 mg daily
    • Verapamil 180 mg CD daily
  • Hydralazine 25 mg qid
  • Simvastatin 80 mg daily
  • Verapamil 180 mg CD daily